Sources | Names Used |
---|---|
CTRPv2 | selumetinib:vorinostat (8:1 mol/mol) |
PharmacoGx | selumetinib:vorinostat (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYR61 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
mRNA | KRT20 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | RTKN | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
mRNA | MITF | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-06 |
mRNA | PFN2 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-06 |
mRNA | PHLPP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | MESDC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | PCDH18 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
mRNA | FAM127A | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-06 |
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |